Most readers are probably aware that it has been getting more difficult to find decent values in the current environment. When I ran my screens for valuation, I stumbled upon AT&T (T) and Verizon (VZ), which are telecom behemoths in the US.
Top 10 Low Price Stocks To Buy Right Now: Pall Corporation(PLL)
Pall Corporation, together with its subsidiaries, manufactures and markets filtration, purification, and separation products and integrated systems solutions worldwide. The company?s Life Sciences segment provides technologies that facilitate the process of drug discovery, development, regulatory validation, and production used in the research laboratories, pharmaceutical and biotechnology industries, food and beverage industry, blood centers, and hospitals at the point of patient care. It also offers medical products that enhance the safety of the use of blood products in patient care and help control the spread of infections in hospitals; and cell therapy products that enable technologies for the regenerative medicine market. In addition, this segment sells various filtration and purification technologies, appurtenant hardware, and engineered systems for the development and commercialization of chemically synthesized and biologically derived drugs, plasma, and vaccines, as well as offers filtration solutions; validation services to drug manufacturers; and laboratory products for use in drug research and discovery, quality control testing, and environmental monitoring applications. Further, it serves the filtration needs of the food and beverage market. The company?s Industrial segment provides enabling and process enhancing technologies for the industrial market. It offers filtration and fluid monitoring equipment to the aerospace industry; filtration and purification technologies for the semiconductor, data storage, fiber optic, advanced display, and materials markets; and a suite of contamination control solutions for chemical, gas, water, chemical mechanical polishing, and photolithography processes. This segment also provides various technologies to producers of energy, oil, gas, renewable and alternative fuels, electricity, chemicals, and municipal water. The company was founded in 1946 and is headquartered in Port Washington, New Yo rk.
Advisors' Opinion:- [By John Divine]
Filtration systems producer Pall (NYSE: PLL ) leads off today's list, having slumped 5.1%. The company reported quarterly results after the markets closed yesterday, and investors were underwhelmed. Sales didn't live up to expectations, although earnings actually beat estimates. The company's outlook really stung shares: Pall said that European expansion was going well, while operations in China were sluggish. Apart from that being the inverse version of what Wall Street wanted to hear, the company also lowered guidance for the fiscal year.
- [By James Miller Phd]
Pall Corporation (PLL) is a supplier of filtration, separation and purification technologies, principally made by the company, for the removal of solid, liquid and gaseous contaminants from a range of liquids and gases. The company serves customers through two businesses globally: Life Sciences and Industrial. While Pall competes with many companies in the Life Sciences markets and Industrial, few companies operate in both, like ESCO Technologies Inc. (ESE) and Danaher Corp. (DHR).
- [By Mike Deane]
On Tuesday, Pall Corp (PLL) announced a 10% raise to its quarterly dividend.
The East Hills, NY-based filtration, purification and separation products supplier will now pay a monthly dividend of 27.5 cents, which is up from its previous quarterly payout of 25 cents. On an annualized basis, PLL will now pay shareholders $1.1 per share.
The dividend is payable on November 8, 2013 to all shareholders on record as of October 18, 2013. The ex-dividend date is October 16, 2013.
PLL shares were down just 5 cents, or .06%, at market close on Tuesday. The company’s stock is up more than 24% YTD.
Hot Long Term Companies To Buy For 2014: Apollo Commercial Real Estate Finance (ARI)
Apollo Commercial Real Estate Finance, Inc., a real estate investment trust, engages in originating, acquiring, investing in, and managing performing commercial first mortgage loans, commercial mortgage-backed securities, mezzanine financings, and other commercial real estate-related debt investments in the United States. The company is qualified as a real estate investment trust (REIT) under the Internal Revenue Code. As a REIT, it would not be subject to federal income taxes, if it distributes at least 90% of its REIT taxable income to its stockholders. The company was founded in 2009 and is headquartered in New York, New York.
Advisors' Opinion:- [By Rich Duprey]
Mortgage real estate investment trust�Apollo Commercial Real Estate Finance� (NYSE: ARI ) announced this morning its second-quarter dividend for its 8.625% Series A cumulative redeemable perpetual preferred stock�of $0.5391�per share for the period ending July 15. That's the same rate it's paid for the past three quarters after it was increased 21% from $0.4432 per share.
Hot Long Term Companies To Buy For 2014: Cleveland BioLabs Inc.(CBLI)
Cleveland BioLabs, Inc., a biotechnology company, engages in the discovery, development, and commercialization of products for cancer treatment, and protection of normal tissues from radiation and other acute stresses. Its products include Protectan CBLB502, a radioprotectant molecule with multiple medical and defense applications for reducing injury from acute stresses, such as radiation and chemotherapy by mobilizing various natural cell protecting mechanisms, including inhibition of apoptosis, reduction of oxidative damage, and induction of factors that induce protection and regeneration of stem cells in bone marrow and the intestines; Protectan CBLB612, a modified lipopeptide mycoplasma that acts as a stimulator and mobilizer of hematopoietic stem cells to peripheral blood, providing hematopoietic recovery during chemotherapy and during donor preparation for bone marrow transplantation; and Curaxins, which are small molecules intended to destroy tumor cells by simultan eously targeting two regulators of apoptosis. The company has a strategic research partnership with Roswell Park Cancer Institute to develop its anticancer and radioprotectant drug candidates; a strategic partnership with ChemBridge Corporation to access a chemical library of 214,000 compounds; and a strategic alliance with The Cleveland Clinic Foundation (CCF). It also has a cooperative research and development agreement with the Uniformed Services University of the Health Sciences; the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; and CCF to evaluate its radioprotective drug candidates and their effects on intracellular and extracellular signaling pathways. The company was founded in 2003 and is headquartered in Buffalo, New York.
Advisors' Opinion:- [By Lisa Levin]
Cleveland BioLabs (NASDAQ: CBLI) plummeted 32.65% to $0.7610 as the company reported that BARDA has terminated negotiations related to its proposal for further development of Entolimod.
- [By Lisa Levin]
Cleveland BioLabs (NASDAQ: CBLI) shares tumbled 34.67% to touch a new 52-week low of $0.74 as the company reported that BARDA has terminated negotiations related to its proposal for further development of Entolimod.
Hot Long Term Companies To Buy For 2014: Cencosud SA (CNCO)
Cencosud SA (Cencosud) is a Chile-based holding company primarily engaged in the retail sector. The Company�� activities include the management and operation of a network of supermarkets, home centers, department stores and shopping malls, which operate under such names as Jumbo, Disco & Vea, Santa Isabel, Easy, Paris, Blaisten and GBarbosa, among others. The Company�� business also comprises the provision of consumer financial services and insurance brokerage, as well as it operates family entertainment centers and a travel agency. Through its subsidiaries and affiliates, the Company has operations established in Argentina, Brazil, Chile, Colombia and Peru. As of December 31, 2010, the Company was a 25.74%-owned affiliate of Inversiones Quinchamali Limitada.
Advisors' Opinion:- [By Will Ashworth]
In terms of growth, Asia is where the company is achieving its greatest success. Operating joint ventures in China, India and Japan, Aegon’s gross deposits in new markets grew 31% in fiscal 2013 to $19.8 billion. Its underlying earnings before tax have grown 28% over the last two fiscal years, with fee-based earnings representing a much bigger part of its business than in the past. That�� a good thing, because fee-based earnings don�� have nearly the same bite if things go south than assets on your own balance sheet. Its operations outside of Europe are getting stronger, providing the diversification necessary to survive financial hiccups. As far as insurers go, AEG is one of the best cheap stocks worth owning.
Cheap Stocks to Buy: Cencosud S.A. (CNCO)Cencosud is one of the largest retailers in Latin America. It operates grocery stores, home improvement stores and department stores in five countries including Chile, its home base. Its stock is down 51% over the past year for several reasons, including a deal falling through that would have seen it sell 51% of its credit card operations in Chile and Argentina to Itau Unibanco (ITUB) and using the proceeds to reduce its heavy debt load. Add to that a major devaluation of the peso in Argentina, where it generates a quarter of its overall revenue, and you have investors in a full-on panic.
Hot Long Term Companies To Buy For 2014: Cerner Corp (CERN)
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT) solutions, services, devices and hardware. Cerner solutions optimize processes for healthcare organizations. These solutions are licensed by approximately 9,300 facilities globally, including more than 2,650 hospitals; 3,750 physician practices 40,000 physicians; 500 ambulatory facilities, such as laboratories, ambulatory centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; 40 employer sites and 1,600 retail pharmacies. The Company operates in two segments: domestic and global. The domestic segment includes revenue contributions and expenditures associated with business activity in the United States. The global segment includes revenue contributions and expenditures linked to business activity in Argentina, Aruba, Australia, Austria, Canada, Cayman Islands, Chile, China (Hong Kong), Egypt, England, France, Germany, Guam, India, Ireland, Italy, Japan, Malaysia, Morocco, Puerto Rico, Qatar, Saudi Arabia, Singapore, Spain, Sweden, Switzerland and the United Arab Emirates. On May 23, 2011, the Company acquired Resource Systems, Inc. On October 17, 2011, the Company acquired Clairvia, Inc. Effective March 18, 2013, it acquired Labotix Automation Inc.
The Company designs and develops software solutions on the unified Cerner Millennium architecture, a person-centric computing framework, which combines clinical, financial and management information systems. This architecture allows providers to access an individual�� electronic health record (EHR) at the point of care, and it organizes and proactively delivers information to meet the specific needs of physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals and consumers. It also offers a range of services, including implementation and training, remote hosting, operational management services, revenue cycle services, support and maintenance, healthcare data analysis, clinical proc! ess optimization, transaction processing, employer health centers, employee wellness programs and third party administrator (TPA) services for employer-based health plans.
The Company offers a longitudinal, person-centric EHR, which gives clinicians electronic access to the right information at the right time and place to achieve optimal health outcomes. Medical information and care regimens accessible from home enables consumers to manage their conditions and adhere to treatment plans, creating a medium between physicians and individuals. Its Cerner ITWorks is a suite of services, which creates an alignment between Cerner and its clients. Its Cerner RevWorks includes solutions and services to help healthcare organizations improve their revenue cycle functions. It offers clinic, pharmacy and wellness services directly to employers.
The Company's Healthe Intent Chart Search includes clinical meanings of words located within the electronic medical record (EMR), as well as the context in which those words occur to create algorithms that identify and rank information contextually. The Healthe Intent platform also provides the ability to apply algorithms against contextual clinical activity to recommend clinical action.
The Company competes with Allscripts Healthcare Solutions, Inc., Computer Programs and Systems, Inc. (CPSI), Epic Systems Corporation, GE Healthcare Technologies, Healthcare Management Systems, Inc. (HMS), Healthland, Inc., Computer Sciences Corporation (iSoft), Keane, Inc., McKesson Corporation, Medical Information Technology, Inc. (Meditech), Siemens Medical Solutions Health Services Corporation, Quadramed Corporation, Accenture plc, Affiliated Computer Services (ACS), Cap Gemini S. A., Computer Task Group, Inc. (CTGHS), Dell, Inc., Deloitte Consulting LLP, Hewlett-Packard Company, IBM Corporation, maxIT Healthcare LLC, AmazingCharts.com, Inc., Athenahealth, Inc., eClinicalWorks LLC, e-MDs, Inc., Greenway Medical Technologies, MED3000, Inc., Quality Sy! stems, In! c., Conceptual MindWorks, Inc., Vitera Healthcare Solutions, API Healthcare, CapsuleTech, Inc., CareFusion Corporation, GE Healthcare Technologies, iSirona, LLC, McKesson Corporation, Omnicell, Inc., Accretive Health, Inc., Capario, Inc., Emdeon Corporation, McKesson Corporation, MedAssets, Inc., Optum, Inc., SSI Group, Inc. and 3M Company.
Advisors' Opinion:- [By Todd Campbell]
Although McKesson notched respectable top-line growth for its low-margin distribution business, sales in its higher-margin technology solutions unit dipped 6% to $770 million. Rising competitive pressure in the healthcare IT space from Cerner (NASDAQ: CERN ) and the privately held Epic continue to negatively affect demand for the company's Horizon clinical software program. Regardless, the unit still delivered operating profit of $125 million, for an operating margin of 16.23%.
- [By Dan Caplinger]
Quality Systems certainly has plenty of growth potential. Late last month, competitor Cerner (NASDAQ: CERN ) announced record bookings for its first quarter, and with a strong backlog and favorable guidance for the full 2013 year, Cerner is finding promising ways forward to grow its business. Cerner's results point to strength not just within the company but for the broader industry as well, and Quality Systems is poised to tap into the generally positive environment.
- [By Johnson Research Group]
Short Squeeze Candidate #1: Cerner (CERN)
Click to Enlarge Healthcare has been in the air lately with the implementation of the Affordable Care Act. The uncertainty surrounding the changes in legislation has traders betting against a number of companies, including Cerner (CERN).
Hot Long Term Companies To Buy For 2014: Anika Therapeutics Inc.(ANIK)
Anika Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body. The company offers orthobiologics products for providing relief from the pain of osteoarthritis, and regenerating damaged tissue, such as cartilage defects; ORTHOVISC for the treatment of osteoarthritis of the knee and various joints; ORTHOVISC mini for the treatment of osteoarthritis in small joints; and MONOVISC, a single injection product used for the treatment of osteoarthritis in various joints. It also provides wound care products that comprise Hyalograft 3D for the regeneration of skin; and Hyalomatrix for the treatment of burns and ulcers. In addition, the company offers AMVISC, AMVISC Plus, STAARVISC-II, Optivisc, and AnikaVisc which are injectable HA products used as viscoelastic agents in o phthalmic surgical procedures, such as cataract extraction and intraocular lens implantation. Further, it provides INCERT, a HA based product for the prevention of post-surgical adhesions; Hyalobarrier and Hyalobarrier Endo, which are post operative adhesion barriers for abdominal indications; and HYVISC, an injectable HA product used for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine osteoarthritis. Additionally, the company offers Merogel, a product used for the treatment of ear, nose, and throat disorders; and provides dermal fillers for facial wrinkles and scar remediation under the ELEVESS and HYDRELLE brand names. It markets its products directly, as well as through a network of distributors primarily in the United States and Europe. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.
Advisors' Opinion:- [By STOCKPICKR]
Anika Therapeutics (ANIK), together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair in the U.S., Europe, and internationally. This stock closed up 2.1% to $48.86 in Monday's trading session.
Monday's Volume: 1.25 million
Three-Month Average Volume: 347,160
Volume % Change: 272%From a technical perspective, ANIK jumped higher here right above some near-term support at $46 with above-average volume. This spike higher on Monday briefly pushed shares of ANIK into breakout territory, since the stock flirted with some near-term overhead resistance levels at $49.21 to $49.37. Shares of ANIK tagged an intraday high of $51.40, before it closed below that level at $48.86. Market players should now look for a continuation move to the upside in the short-term if ANIK manages to take out Monday's high of $51.36 to its 52-week high of $52.49 with high volume.
Traders should now look for long-biased trades in ANIK as long as it's trending above Monday's low of $47.57 or above $46 and then once it sustains a move or close above $51.36 to $52.49 with volume that hits near or above 347,160 shares. If that move begins soon, then ANIK will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $55 to $60.
Hot Long Term Companies To Buy For 2014: Xing AG (O1BC)
Xing AG, formerly Open Business Club AG, is a Germany-based company engaged in the provision and maintenance of online business communication services. It offers companies enterprise solutions afforded by Web 2.0 and manages the communities for professional networking. It supplies support in establishing new business contacts, expanding and managing the network of contacts and organizing meetings and events. It enables its customers to identify experts in several fields and receive advice on any topic as well as promote themselves in their business environments. It serves a number of networkers worldwide. The product portfolio consists of four categories: openBC platform; openBC Premium Groups; openBC mobile, with mobile phone access; openBC plugin, supporting Lotus Notes and Microsoft Outlook. The solutions are offered in 16 languages and data as well as privacy protection is provided. It co-operates with epublica, a Web-based corporate solution provider and Sevenval AG. Advisors' Opinion:- [By Jonathan Morgan]
RWE AG (RWE), Germany�� second-largest utility, slipped 2.4 percent after RBC Capital Markets cut its recommendation on the stock. Lufthansa followed its European peers higher, recovering some of its Aug. 2 selloff. Xing AG (O1BC), the business social network, jumped the most since October as Deutsche Bank AG (DBK) upgraded its rating on the shares.
No comments:
Post a Comment